Oncotarget

Vol 10, No 40

June 18, 2019

View Archive »

Order a Reprint

About The Cover

The cover for issue 40 of Oncotarget features Figure 7, "Model figure of ETHE1 roles in FAP," by Witherspoon, et al.

Table of Contents

Editorial

Targeting proteostasis and autophagy in SMARCB1-deficient malignancies: where next?

Targeting proteostasis and autophagy in SMARCB1-deficient malignancies: where next?

https://doi.org/10.18632/oncotarget.26970

Pavlos Msaouel, Alessandro Carugo,  and Giannicola Genovese
3979-3981
PDF  |  How to cite  |  Order a Reprint

The non-random landscape of somatically-acquired uniparental disomy in cancer

The non-random landscape of somatically-acquired uniparental disomy in cancer

https://doi.org/10.18632/oncotarget.26987

Pau Erola, Keyvan Torabi, Rosa Miró,  and Jordi Camps
3982-3984
PDF  |  How to cite  |  Order a Reprint

Cancer vaccines: what’s next?

Cancer vaccines: what’s next?

https://doi.org/10.18632/oncotarget.27006

Stéphane Depil, Paola Bonaventura,  and Vincent Alcazer
3985-3987
PDF  |  How to cite  |  Order a Reprint

VEGF-C as a putative therapeutic target in cancer

VEGF-C as a putative therapeutic target in cancer

https://doi.org/10.18632/oncotarget.27007

Signe R. Michaelsen, Hans S. Poulsen,  and Petra Hamerlik
3988-3990
PDF  |  How to cite  |  Order a Reprint

Diffuse large B-cell lymphoma: the stuff of cell-of-origin and microenvironment

Diffuse large B-cell lymphoma: the stuff of cell-of-origin and microenvironment

https://doi.org/10.18632/oncotarget.27013

Stefano A. Pileri, Maria Carmela Vegliante,  and Sabino Ciavarella
3991-3993
PDF  |  How to cite  |  Order a Reprint

Advanced MRI in neuro-oncology: can we proceed without inclusion of energy metabolism?

Advanced MRI in neuro-oncology: can we proceed without inclusion of energy metabolism?

https://doi.org/10.18632/oncotarget.27015

Andreas Stadlbauer, Michael Buchfelder, Arnd Dörfler,  and Stefan Oberndorfer
3994-3995
PDF  |  How to cite  |  Order a Reprint

Mesothelioma: Hippo pathway as a target, lessons from COMMAND

Mesothelioma: Hippo pathway as a target, lessons from COMMAND

https://doi.org/10.18632/oncotarget.27018

Dean A. Fennell,  and Essa Y. Baitei
3996-3997
PDF  |  How to cite  |  Order a Reprint

From rare to well-done: importance of rare tumors in cancer therapeutic advances

From rare to well-done: importance of rare tumors in cancer therapeutic advances

https://doi.org/10.18632/oncotarget.27020

Florence Duffaud, Sophie Piperno-Neumann, Nicolas Penel,  and Jean-Yves Blay
3998-3999
PDF  |  How to cite  |  Order a Reprint

An emerging role of CD9 in stemness and chemoresistance

An emerging role of CD9 in stemness and chemoresistance

https://doi.org/10.18632/oncotarget.27021

Mujib Ullah, Asma Akbar,  and Avnesh S. Thakor
4000-4001
PDF  |  How to cite  |  Order a Reprint

Targeted therapy in CLL: changing the treatment paradigm

Targeted therapy in CLL: changing the treatment paradigm

https://doi.org/10.18632/oncotarget.26964

Christof Schneider, Daniela Steinbrecher,  and Stephan Stilgenbauer
4002-4003
PDF  |  How to cite  |  Order a Reprint

Research Papers

ETHE1 overexpression promotes SIRT1 and PGC1α mediated aerobic glycolysis, oxidative phosphorylation, mitochondrial biogenesis and colorectal cancer

ETHE1 overexpression promotes SIRT1 and PGC1α mediated aerobic glycolysis, oxidative phosphorylation, mitochondrial biogenesis and colorectal cancer

https://doi.org/10.18632/oncotarget.26958

Mavee Witherspoon, Davinder Sandu, Changyuan Lu, Kehui Wang, Robert Edwards, Anthony Yeung, Ozkan Gelincik, Giovanni Manfredi, Steven Gross, Levy Kopelovich,  and Steven Lipkin
4004-4017
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma

Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma

https://doi.org/10.18632/oncotarget.26998

Celina Ang, Samuel J. Klempner, Siraj M. Ali, Russell Madison, Jeffrey S. Ross, Eric A. Severson, David Fabrizio, Aaron Goodman, Razelle Kurzrock, James Suh,  and Sherri Z. Millis
4018-4025
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Somatic molecular analysis augments cytologic evaluation of pancreatic cyst fluids as a diagnostic tool

Somatic molecular analysis augments cytologic evaluation of pancreatic cyst fluids as a diagnostic tool

https://doi.org/10.18632/oncotarget.26999

Ali Sakhdari, Parnian Ahmadi Moghaddam, Chi Young Ok, Otto Walter, Keith Tomaszewicz, Mandi-Lee Caporelli, Xiuling Meng, Jennifer LaFemina, Giles Whalen, Edward Belkin, Jaroslav Zivny, Wahid Wassef, Bruce A. Woda, Lloyd M. Hutchinson,  and Ediz F. Cosar
4026-4037
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Mutations of the MAPK/TSC/mTOR pathway characterize periventricular glioblastoma with epithelioid SEGA-like morphology–morphological and therapeutic implications

Mutations of the MAPK/TSC/mTOR pathway characterize periventricular glioblastoma with epithelioid SEGA-like morphology–morphological and therapeutic implications

https://doi.org/10.18632/oncotarget.27005

Maria-Magdalena Georgescu, Yan Li, Mohammad Zahidul Islam, Christina Notarianni, Hai Sun, Adriana Olar,  and Gregory N. Fuller
4038-4052
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Impact of eIF4E phosphorylation at Ser209 via MNK2a on tumour recurrence after curative surgery in localized clear cell renal cell carcinoma

Impact of eIF4E phosphorylation at Ser209 via MNK2a on tumour recurrence after curative surgery in localized clear cell renal cell carcinoma

https://doi.org/10.18632/oncotarget.27017

Osamu Ichiyanagi, Hiromi Ito, Sei Naito, Takanobu Kabasawa, Hidenori Kanno, Takafumi Narisawa, Masaki Ushijima, Yuta Kurota, Michinobu Ozawa, Toshihiko Sakurai, Hayato Nishida, Tomoyuki Kato, Mitsunori Yamakawa,  and Norihiko Tsuchiya
4053-4068
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Clinical Research Papers

Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma

Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma

https://doi.org/10.18632/oncotarget.23861

Yongshun Chen, Xiaoyuan Wu, Daxuan Hao, Xinyu Cheng, Lei Zhang, Yougai Zhang, Shaobo Ke, Wei Shi,  and Chunyu He
4069-4078
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

Corrections

Correction: Glucocorticoid impairs cell-cell communication by autophagy-mediated degradation of connexin 43 in osteocytes

Correction: Glucocorticoid impairs cell-cell communication by autophagy-mediated degradation of connexin 43 in osteocytes

https://doi.org/10.18632/oncotarget.27035

Junjie Gao, Tak Sum Cheng, An Qin, Nathan J. Pavlos, Tao Wang, Kai Song, Yan Wang, Lianzhi Chen, Lin Zhou, Qing Jiang, Hiroshi Takayanagi, Sheng Yan,  and Minghao Zheng
4079-4079
Correction  |  PDF  |  How to cite


Copyright © 2019 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC